TY - JOUR
T1 - Frequency of nonsentinel lymph node metastasis in melanoma
AU - McMasters, Kelly M.
AU - Wong, Sandra L.
AU - Edwards, Michael J.
AU - Chao, Celia
AU - Ross, Merrick I.
AU - Noyes, R. Dirk
AU - Viar, Vicki
AU - Cerrito, Patricia B.
AU - Reintgen, Douglas S.
N1 - Funding Information:
Acknowledgments: Supported by a grant from Schering Oncology-Biotech and the Center for Advanced Surgical Technologies (CAST) of Norton Hospital, Louisville, KY. The authors wish to thank Carla Shelton, Sherri Matthews, and Diana Simpson for their continued dedication to the data management and coordination of this study.
PY - 2002
Y1 - 2002
N2 - Background: Completion lymph node dissection (CLND) may not be necessary for some patients because nodal metastasis is rarely detected beyond the sentinel lymph nodes (SLNs). This analysis was performed to determine, among patients with positive SLNs, the rate of nodal metastasis found in nonsentinel nodes (NSNs). Methods: This analysis includes patients with positive sentinel nodes, detected by hematoxylin and eosin (H&E) staining or immunohistochemistry (IHC), who then underwent CLND. Results: This analysis included 274 patients with at least one positive SLN who underwent CLND of 282 involved regional nodal basins. Of the 282 SLN-positive nodal basins, 45 (16%) were found to have positive NSNs in the CLND specimen. Breslow thickness, Clark level, presence of ulceration, histological subtype, presence of vertical growth phase, evidence of regression, presence of lymphovascular invasion, number of positive SLNs, age, sex, and presence of multiple draining nodal basins were not predictive of positive nodes in the CLND specimen. Patients with SLN metastases detected only by IHC had an equal likelihood of having positive NSNs as those patients with positive SLNs on H&E examination. Conclusions: No patient population could be identified with minimal risk of non-SLN metastasis. When a positive SLN is identified on either H&E staining or IHC, CLND should be performed routinely.
AB - Background: Completion lymph node dissection (CLND) may not be necessary for some patients because nodal metastasis is rarely detected beyond the sentinel lymph nodes (SLNs). This analysis was performed to determine, among patients with positive SLNs, the rate of nodal metastasis found in nonsentinel nodes (NSNs). Methods: This analysis includes patients with positive sentinel nodes, detected by hematoxylin and eosin (H&E) staining or immunohistochemistry (IHC), who then underwent CLND. Results: This analysis included 274 patients with at least one positive SLN who underwent CLND of 282 involved regional nodal basins. Of the 282 SLN-positive nodal basins, 45 (16%) were found to have positive NSNs in the CLND specimen. Breslow thickness, Clark level, presence of ulceration, histological subtype, presence of vertical growth phase, evidence of regression, presence of lymphovascular invasion, number of positive SLNs, age, sex, and presence of multiple draining nodal basins were not predictive of positive nodes in the CLND specimen. Patients with SLN metastases detected only by IHC had an equal likelihood of having positive NSNs as those patients with positive SLNs on H&E examination. Conclusions: No patient population could be identified with minimal risk of non-SLN metastasis. When a positive SLN is identified on either H&E staining or IHC, CLND should be performed routinely.
KW - Lymph node dissection
KW - Lymphatic mapping
KW - Melanoma
KW - Nonsentinel node
KW - Sentinel lymph node
UR - http://www.scopus.com/inward/record.url?scp=0036202219&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036202219&partnerID=8YFLogxK
U2 - 10.1245/aso.2002.9.2.137
DO - 10.1245/aso.2002.9.2.137
M3 - Article
C2 - 11888869
AN - SCOPUS:0036202219
SN - 1068-9265
VL - 9
SP - 137
EP - 141
JO - Annals of surgical oncology
JF - Annals of surgical oncology
IS - 2
ER -